Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Amylyx Pharmaceuticals (Nasdaq: AMLX) has announced its participation in the upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference. The company's management will deliver a presentation at this virtual event on Wednesday, February 12, 2025, at 2:00 p.m. ET.
Interested parties can access a live webcast of the presentation through the 'Events and Presentations' section of Amylyx's investor relations website at investors.amylyx.com/events-presentations. The presentation recording will remain available for replay on the company's website for 90 days after the event.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha annunciato la sua partecipazione alla prossima 35a Conferenza Annuale sulle Scienze della Salute di Oppenheimer. La direzione dell'azienda terrà una presentazione in questo evento virtuale il mercoledì 12 febbraio 2025, alle 14:00 ET.
Le parti interessate possono accedere a una diretta della presentazione attraverso la sezione 'Eventi e Presentazioni' del sito web per le relazioni con gli investitori di Amylyx all'indirizzo investors.amylyx.com/events-presentations. La registrazione della presentazione rimarrà disponibile per la visione per 90 giorni dopo l'evento.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha anunciado su participación en la próxima 35ª Conferencia Anual sobre Ciencias de la Salud de Oppenheimer. La dirección de la compañía realizará una presentación en este evento virtual el miércoles 12 de febrero de 2025, a las 2:00 p.m. ET.
Las partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la sección 'Eventos y Presentaciones' del sitio web de relaciones con inversionistas de Amylyx en investors.amylyx.com/events-presentations. La grabación de la presentación estará disponible para su reproducción en el sitio web de la compañía durante 90 días después del evento.
Amylyx Pharmaceuticals (Nasdaq: AMLX)은 다가오는 오펜하이머 제35회 연례 생명과학 의료 회의에 참여한다고 발표했습니다. 회사 경영진은 2025년 2월 12일 수요일 오후 2시 ET에 이 가상 이벤트에서 발표를 진행합니다.
관심 있는 분들은 Amylyx의 투자자 관계 웹사이트에서 '이벤트 및 발표' 섹션을 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다: investors.amylyx.com/events-presentations. 발표 녹화는 이벤트 종료 후 90일 동안 회사 웹사이트에서 재시청할 수 있습니다.
Amylyx Pharmaceuticals (Nasdaq: AMLX) a annoncé sa participation à la prochaine 35e Conférence Annuelle sur les Sciences de la Vie et de la Santé d'Oppenheimer. La direction de l'entreprise présentera lors de cet événement virtuel le mercredi 12 février 2025, à 14h00 ET.
Les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section 'Événements et Présentations' du site web des relations investisseurs d'Amylyx à l'adresse investors.amylyx.com/events-presentations. L'enregistrement de la présentation sera disponible en rediffusion sur le site de l'entreprise pendant 90 jours après l'événement.
Amylyx Pharmaceuticals (Nasdaq: AMLX) hat seine Teilnahme an der kommenden 35. jährlichen Oppenheimer Healthcare Life Sciences-Konferenz angekündigt. Das Management des Unternehmens wird am Mittwoch, den 12. Februar 2025, um 14:00 Uhr ET eine Präsentation bei dieser virtuellen Veranstaltung halten.
Interessierte können über den Bereich 'Veranstaltungen und Präsentationen' auf der Investoren-Relations-Website von Amylyx unter investors.amylyx.com/events-presentations auf einen Live-Stream der Präsentation zugreifen. Die Aufzeichnung der Präsentation bleibt für 90 Tage nach der Veranstaltung auf der Website des Unternehmens verfügbar.
- None.
- None.
A live webcast of the presentation can be accessed under “Events and Presentations” in the Investor section of the Company’s website, https://investors.amylyx.com/events-presentations, and will be available for replay for 90 days following the event.
About Amylyx Pharmaceuticals
At Amylyx, our mission is to usher in a new era of treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are currently focused on three investigational therapies across several neurodegenerative, neuroendocrine, and endocrine diseases in which we believe they can make the greatest impact. For more information, visit amylyx.com and follow us on LinkedIn and X. For investors, please visit investors.amylyx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250210175677/en/
Media
Amylyx Media Team
+1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors
Lindsey Allen
Amylyx Pharmaceuticals, Inc.
+1 (857) 320-6244
Investors@amylyx.com
Source: Amylyx Pharmaceuticals, Inc.
FAQ
When is Amylyx Pharmaceuticals (AMLX) presenting at the Oppenheimer Healthcare Conference 2025?
How can investors watch AMLX's Oppenheimer Conference presentation?
How long will AMLX's Oppenheimer Conference presentation be available for replay?
Is the Oppenheimer Healthcare Conference 2025 where AMLX is presenting in-person or virtual?
